Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT03162120
Eligibility Criteria:
Inclusion Criteria:
* patients with AF
* recently converted to sinus rhythm (\>24hrs and \< 7 days)
* admitted in the 3rd University Cardiology Clinic of Ippokrateion Hospital
* eligible to participate in the study and follow the study procedures
* signed informed consent
Exclusion Criteria:
* use of IC antiarrhythmic agents or
* Sotalol during the last 48 hours,
* chronic use of oral or intravenous Amiodarone for the last 48 hours,
* recent acute coronary syndrome,
* heart failure New York Heart Association class III or IV,
* severe left ventricular dysfunction with left ventricular ejection fraction \<40%,
* atrioventricular conduction disorders (atrioventricular block,
* complete left bundle branch block and bi-fascicular block),
* heart rate \< 50 bpm,
* sick sinus syndrome,
* thyroid dysfunction and severe pulmonary, renal, or
* liver disease
* \- not eligible to participate in the study and follow the study procedures
* no signed informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT03162120
Study Brief:
Protocol Section:
NCT03162120